Replies to post #691613 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

Likely. UCLA & James River too.

[Smitty5150]

So who owns the proprietary rights to DCVAX?
DCVax-L, a personalized immune therapy for cancer, is owned by Northwest Biotherapeutics. It's a product they've been developing for the treatment of various types of cancer, including glioblastoma multiforme (GBM), a particularly aggressive form of brain cancer.

Does UCLA own the rights to DCVax?
No, UCLA (University of California, Los Angeles) does not own the rights to DCVax-L. Northwest Biotherapeutics is the company that owns the proprietary rights to DCVax-L. However, it's worth noting that UCLA may have been involved in the early research or development that contributed to the creation of DCVax-L, as academic institutions often collaborate with biotech companies in such endeavors.